Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Kestra Medical Technologies, Ltd. (KMTS : NSDQ)
 
 • Company Description   
Kestra Medical Technologies, Ltd. is a commercial-stage wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies. Kestra Medical Technologies, Ltd. is based in KIRKLAND, Wash.

Number of Employees: 330

 
 • Price / Volume Information   
Yesterday's Closing Price: $26.22 Daily Weekly Monthly
20 Day Moving Average: 269,369 shares
Shares Outstanding: 51.45 (millions)
Market Capitalization: $1,348.99 (millions)
Beta:
52 Week High: $30.00
52 Week Low: $13.25
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 19.18% 16.06%
12 Week 63.36% 56.59%
Year To Date % %
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
3933 Lake Washington Blvd NE Suite 200
-
Kirkland,WA 98033
USA		 ph: 425-279-8002
fax: -		 investor.relations@kestramedical.com http://www.kestramedical.com
 
 • General Corporate Information   
Officers
Brian Webster - President and Chief Executive Officer
Jeff Schwartz - Chairman
Vaseem Mahboob - Chief Financial Officer
Traci Umberger - General Counsel; Chief Administrative Officer and
Christopher Gordon - Director

Peer Information
Kestra Medical Technologies, Ltd. (BJCT)
Kestra Medical Technologies, Ltd. (CADMQ)
Kestra Medical Technologies, Ltd. (APNO)
Kestra Medical Technologies, Ltd. (UPDC)
Kestra Medical Technologies, Ltd. (IMTIQ)
Kestra Medical Technologies, Ltd. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: G52441105
SIC: 3841
Fiscal Year
Fiscal Year End: April
Last Reported Quarter: 07/01/25
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding: 51.45
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $1,348.99 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.56 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-2.15 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 7.31
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: 77.99%
Sales Growth
vs. Year Ago Period: 51.55%
vs. Previous Quarter: 12.41%
ROE
10/31/25 - -
07/31/25 - -
04/30/25 - -
ROA
10/31/25 - -
07/31/25 - -
04/30/25 - -
Current Ratio
10/31/25 - -
07/31/25 - 6.84
04/30/25 - 6.72
Quick Ratio
10/31/25 - -
07/31/25 - 6.84
04/30/25 - 6.72
Operating Margin
10/31/25 - -
07/31/25 - -
04/30/25 - -
Net Margin
10/31/25 - -
07/31/25 - -
04/30/25 - -
Pre-Tax Margin
10/31/25 - -
07/31/25 - -
04/30/25 - -190.05
Book Value
10/31/25 - -
07/31/25 - 3.59
04/30/25 - 4.00
Inventory Turnover
10/31/25 - -
07/31/25 - -
04/30/25 - -
Debt-to-Equity
10/31/25 - -
07/31/25 - 0.23
04/30/25 - 0.20
Debt-to-Capital
10/31/25 - -
07/31/25 - 18.39
04/30/25 - 16.67
 

Powered by Zacks Investment Research ©